1101121-05-4

Basic information

• Product Name: 5-broMopyrazolo[1,5-a]pyridine-3-carboxylic acid
• Synonyms: 5-broMopyrazolo[1,5-a]pyridine-3-carboxylic acid
• CAS NO: 1101121-05-4
• Molecular Formula: C₈H₅BrN₂O₂
• Molecular Weight: 241.0415
• Mol File: 1101121-05-4.mol

Chemical Properties

• Appearance: /
• Density: 1.89±0.1 g/cm3(Predicted)
• Storage Temp.: 2-8°C
• PKA: -1.14±0.41(Predicted)
• CAS DataBase Reference: 5-broMopyrazolo[1,5-a]pyridine-3-carboxylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 5-broMopyrazolo[1,5-a]pyridine-3-carboxylic acid(1101121-05-4)
• EPA Substance Registry System: 5-broMopyrazolo[1,5-a]pyridine-3-carboxylic acid(1101121-05-4)

Safety Data

• Hazardous Substances Data: 1101121-05-4(Hazardous Substances Data)

Usage

Uses

Used in Scientific Research:
5-Bromopyrazolo[1,5-a]pyridine-3-carboxylic acid is used as a research chemical for the development and synthesis of various drugs and specialized chemical products. Its unique structure and reactivity make it a valuable compound in the field of medicinal chemistry and pharmaceutical research.
Used in Drug Development:
5-Bromopyrazolo[1,5-a]pyridine-3-carboxylic acid is used as a key intermediate in the synthesis of new drug candidates. Its presence in the molecular structure can potentially influence the pharmacological properties of the final drug product, making it an important component in the drug discovery process.
Used in Chemical Synthesis:
5-Bromopyrazolo[1,5-a]pyridine-3-carboxylic acid is used as a building block in the synthesis of complex organic molecules. Its reactivity and structural features make it a versatile compound for creating a wide range of specialized chemical products.

Upstream product

• 885276-93-7 ethyl 5-bromopyrazolo[1,5-a]pyridine-3-carboxylate 

Downstream Products

• 1394839-49-6 5-((2R,4S)-2-(3-cyano-5-fluorophenyl)-4-fluoropyrrolidin-1-yl)-N,N-bis(4-methoxybenzyl)pyrazolo[1,5-a]pyridine-3-carboxamide 
• 1394838-11-9 5-((2R,4S)-2-(3-cyano-5-fluorophenyl)-4-fluoropyrrolidin-1-yl)pyrazolo[1,5-a]pyridine-3-carboxamide 
• 1394838-26-6 5-((2R,4S)-4-cyano-2-(3-fluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyridine-3-carboxamide 
• 1394839-53-2 5-((2R,4S)-4-carbamoyl-2-(3-fluorophenyl)pyrrolidin-1-yl)-N,N-bis(4-methoxybenzyl)pyrazolo[1,5-a]pyridine-3-carboxamide 
• 1394838-28-8 5-((2R,4S)-4-carbamoyl-2-(3-fluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyridine-3-carboxamide 
• 1394838-99-3 5-((2R,4R)-2-(3-fluorophenyl)-4-hydroxypyrrolidin-1-yl)-N,N-bis(4-methoxybenzyl)pyrazolo[1,5-a]pyridine-3-carboxamide 
• 1394839-00-9 (3R,5R)-1-(3-(bis(4-methoxybenzyl)carbamoyl)pyrazolo[1,5-a]pyridin-5-yl)-5-(3-fluorophenyl)pyrrolidin-3-yl methanesulfonate 
• 1394839-03-2 5-((2R,4S)-4-cyano-2-(3-fluorophenyl)pyrrolidin-1-yl)-N,N-bis(4-methoxybenzyl)pyrazolo[1,5-a]pyridine-3-carboxamide 
• 1394838-84-6 5-bromo-N,N-bis(4-methoxybenzyl)pyrazolo[1,5-a]pyridine-3-carboxamide 
• 1101119-81-6 2-(5-bromo-2-methylphenylsulfonyl)-5-(5-bromopyrazolo[1,5-a]pyridin-3-yl)-1,3,4-thiadiazole 

Relevant articles and documents

COMPOUNDS AND COMPOSITIONS AS TRK INHIBITORS

The invention provides compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated TRK kinase activity.

PYRAZOLO[1,5-A]PYRIDINES AND THEIR USE IN CANCER THERAPY

Pyrazolo[1,5-a]pyridines are described, including methods for their preparation, and their use as agents or drugs for cancer therapy, both alone or in combination with radiation and/or other anticancer drugs.